Home › Non-Small Cell Lung Cancer › Texas › Abilene

Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Abilene, TX

Isang pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Abilene. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Nagre-recruitPhase 3

Hendrick Medical Center, Abilene

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04267848

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 3

Texas Oncology - West Texas, Abilene

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07144280

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Nagre-recruitPhase 3

Texas Oncology - West Texas, Abilene

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07222566

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Nagre-recruitPhase 3

Texas Oncology - West Texas, Abilene

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06561386

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Nagre-recruitPhase 3

Clinical Study Site, Abilene

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06767514

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

Nagre-recruitPhase 3

Hendrick Health, Abilene

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07195695

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Nagre-recruitPhase 2/3

Local Institution - 007-554B, Abilene

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT04613596

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Nagre-recruitPhase 1/2

USOR Texas Oncology, Abilene

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT05579366

Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa Abilene

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.